Cargando…

A proposed staging system for amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis is a neurodegenerative disorder characterized by progressive loss of upper and lower motor neurons, with a median survival of 2–3 years. Although various phenotypic and research diagnostic classification systems exist and several prognostic models have been generated, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roche, Jose C., Rojas-Garcia, Ricardo, Scott, Kirsten M., Scotton, William, Ellis, Catherine E., Burman, Rachel, Wijesekera, Lokesh, Turner, Martin R., Leigh, P. Nigel, Shaw, Christopher E., Al-Chalabi, Ammar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286327/ https://www.ncbi.nlm.nih.gov/pubmed/22271664 http://dx.doi.org/10.1093/brain/awr351

Ejemplares similares

The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
por: Hanby, Martha F., et al.
Publicado: (2011)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

What causes amyotrophic lateral sclerosis?
por: Martin, Sarah, et al.
Publicado: (2017)

Evolution of white matter damage in amyotrophic lateral sclerosis
por: Gabel, Matt C., et al.
Publicado: (2020)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

An estimate of amyotrophic lateral sclerosis heritability using twin data
por: Al-Chalabi, A, et al.
Publicado: (2010)

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
por: Al-Chalabi, Ammar, et al.
Publicado: (2014)

The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci
por: Wain, Louise V., et al.
Publicado: (2009)

Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019)

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
por: Al-Chalabi, Ammar, et al.
Publicado: (2019)

Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups
por: Ganesalingam, Jeban, et al.
Publicado: (2009)

UK case control study of smoking and risk of amyotrophic lateral sclerosis
por: Opie-Martin, Sarah, et al.
Publicado: (2020)

Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat
por: Jones, Ashley R., et al.
Publicado: (2013)

Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2019)

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2017)

Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis
por: Gaastra, Benjamin, et al.
Publicado: (2016)

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study
por: Garcia-Gancedo, Luis, et al.
Publicado: (2019)

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]
por: Al-Chalabi, Ammar, et al.
Publicado: (2011)

Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
por: Al-Chalabi, Ammar, et al.
Publicado: (2021)

Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis
por: Fang, Fang, et al.
Publicado: (2011)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
por: Fang, Ton, et al.
Publicado: (2018)

A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis
por: Bean, Daniel M., et al.
Publicado: (2020)

A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK
por: Morgan, Sarah, et al.
Publicado: (2017)

Genetic variability in sporadic amyotrophic lateral sclerosis
por: Van Daele, Sien Hilde, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
por: Giovannelli, Ilaria, et al.
Publicado: (2021)

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
por: McLaughlin, Russell L., et al.
Publicado: (2017)

Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’
por: Khalaf, Roaya, et al.
Publicado: (2019)

The impact of age on genetic testing decisions in amyotrophic lateral sclerosis
por: Mehta, Puja R, et al.
Publicado: (2022)

The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis
por: Salmon, Kristiana, et al.
Publicado: (2022)

Reply: The role of DNAJB2 in amyotrophic lateral sclerosis
por: Chen, Han-Jou, et al.
Publicado: (2016)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Reply to: Early white matter changes on diffusion tensor imaging in amyotrophic lateral sclerosis
por: Gabel, Matt C., et al.
Publicado: (2020)

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021)

Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients
por: Joilin, Greig, et al.
Publicado: (2022)

The rise and fall of fasciculations in amyotrophic lateral sclerosis
por: Bashford, James A, et al.
Publicado: (2020)

Sweet food preference in amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2017)

Syntactic processing as a marker for cognitive impairment in amyotrophic lateral sclerosis
por: Tsermentseli, Stella, et al.
Publicado: (2016)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9oql9ub3r8lacksvg10jdm35bn